Pictet Asset Management Holding SA Boosts Stake in HCA Healthcare, Inc. $HCA

Pictet Asset Management Holding SA lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 31.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 161,028 shares of the company’s stock after buying an additional 38,961 shares during the period. Pictet Asset Management Holding SA owned approximately 0.07% of HCA Healthcare worth $76,180,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Union Bancaire Privee UBP SA lifted its position in HCA Healthcare by 21.3% during the first quarter. Union Bancaire Privee UBP SA now owns 654 shares of the company’s stock valued at $309,000 after purchasing an additional 115 shares during the period. Cambient Family Office LLC raised its stake in HCA Healthcare by 25.2% during the 1st quarter. Cambient Family Office LLC now owns 622 shares of the company’s stock valued at $294,000 after buying an additional 125 shares during the last quarter. Merkkuri Wealth Advisors LLC purchased a new position in shares of HCA Healthcare in the 1st quarter worth $43,000. Louisiana State Employees Retirement System purchased a new stake in HCA Healthcare during the first quarter valued at $3,786,000. Finally, Norway Savings Bank boosted its position in HCA Healthcare by 1.9% in the first quarter. Norway Savings Bank now owns 4,656 shares of the company’s stock worth $2,203,000 after purchasing an additional 88 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $392.96 on Tuesday. The firm’s 50 day moving average price is $406.77 and its 200-day moving average price is $464.51. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The stock has a market cap of $87.17 billion, a P/E ratio of 13.51, a PEG ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Robert W. Baird cut their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. TD Cowen lowered their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Oppenheimer decreased their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Sanford C. Bernstein reduced their price objective on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research note on Thursday, June 4th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.